Back to Gene
HCFC1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

HCFC1 gene

The HCFC1 gene provides instructions for making the HCF-1 protein, a critical regulator of gene activity involved in vitamin B12 processing and cell cycle progression.

Normal Function

The HCFC1 gene provides instructions for making a protein called HCF-1, which helps regulate the activity of other genes. HCF-1 interacts with proteins called transcription factors, which bind to specific regions of DNA to control gene activity.

A primary function of HCF-1 is controlling the MMACHC gene, which is involved in processing vitamin B12 (cobalamin). This gene helps convert vitamin B12 into two cofactors:

  • Adenosylcobalamin (AdoCbl): Required for the enzyme methylmalonyl CoA mutase to break down certain amino acids, fatty acids, and cholesterol.
  • Methylcobalamin (MeCbl): Required for the enzyme methionine synthase to convert homocysteine to methionine, an amino acid used to make proteins.

HCF-1 also regulates genes important for the cell cycle (the process by which cells replicate) and plays a role in the distribution of cells in developing tissues, including the brain.

Health Conditions Related to Genetic Changes

Methylmalonic acidemia with homocystinuria

Variants in the HCFC1 gene have been identified in people with methylmalonic acidemia with homocystinuria, cblX type. These variants disrupt the interaction between HCF-1 and transcription factors, impairing MMACHC gene activity. This leads to:

  • A failure to process and transport vitamin B12.
  • A deficiency in both AdoCbl and MeCbl cofactors.
  • A buildup of toxic compounds, including homocysteine.
  • Decreased production of methionine.

This condition causes developmental delay, eye defects, neurological problems, blood abnormalities, and craniofacial abnormalities.

Other disorders

Variants in the HCFC1 gene have also been found in individuals with X-linked intellectual disability. In these cases, the HCF-1 protein has reduced function. This partial reduction disrupts normal brain development but does not severely impact vitamin B12 processing.

Other Names for This Gene

  • CFF
  • HCF
  • HCF-1
  • HCF1
  • HFC1
  • host cell factor 1
  • MGC70925
  • MRX3
  • PPP1R89
  • protein phosphatase 1, regulatory subunit 89
  • VCAF
  • VP16-accessory protein

Frequently Asked Questions

Currently, treatment is supportive and focuses on B12 supplementation and metabolic control. However, research into gene‑replacement strategies and small‑molecule modulators of HCF‑1 activity is underway; patients can inquire about clinical trials through specialized metabolic centers or registries.
Patients often receive high‑dose oral or intramuscular hydroxocobalamin (vitamin B12) to bypass the defective transport. A diet low in methylmalonic acid precursors (certain meats, dairy, and some grains) and rich in folate and vitamin B6 can help reduce homocysteine buildup. Regular monitoring of plasma B12, methylmalonic acid, and homocysteine guides dose adjustments.
comprehensive metabolic panel is first performed, looking for elevated methylmalonic acid and homocysteine levels. If these are high, a targeted genetic test—usually a next‑generation sequencing panel that includes HCFC1—is ordered. The test identifies specific variants that disrupt HCF‑1 function.
HCFC1 defects can lead to developmental delay, seizures, and motor deficits. Early intervention with physical, occupational, and speech therapy, along with seizure management, can improve functional outcomes. Genetic counseling and regular developmental assessments are recommended for families.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA